Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplantWilliam Tse, Morris Kletzel, R. Duerst et al.|Bone Marrow Transplantation|2009Cited by 34
IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patientsDany A. Curi, Nobuko Hijiya, R. Duerst et al.|Bone Marrow Transplantation|2016Cited by 10
Rapid Lymphocyte Recovery And Intravenous Immunoglobulin Independence In Children With Severe Combined Immunodeficiency (SCID) Undergoing Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning (RIC)Jessica Guarino, William Tse, R. Duerst et al.|Transplantation and Cellular Therapy|2009Cited by 0
Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Lymphoblastic Leukemia (ALL) — an Option to ConsiderR. Duerst, Morris Kletzel, David A. Jacobsohn et al.|Transplantation and Cellular Therapy|2009Cited by 0
Promising Outcomes with Tandem Autologous Stem Cell Rescue in ‘Late’ Wilms Tumor RelapseSonali Chaudhury, Morris Kletzel, Nina Merchant et al.|Transplantation and Cellular Therapy|2012Cited by 0